480994-18-1

Upstream product

• 1234708-12-3 (E)-2-(4-(2-(5-nitro-2,6-dioxo-3-propyl-1,2,3,6-tetrahydropyrimidin-4-yl)ethenyl)phenoxy)acetic acid 

Downstream Products

• 480993-71-3 6-[4-(4-phenylpiperazin-1-yl)carbonylmethoxyphenyl]-1-propyl-1,5-dihydro-3H-pyrrolo[3,2-d]pyrimidine-2,4-dione 
• 1234708-05-4 2-[4-(2,4-dioxo-1-propyl-2,3,4,5-tetrahydro-1H-pyrrolo[3,2-d]pyrimidin-6-yl)phenyloxy]-N-phenylacetamide 
• 480992-42-5 2-[4-(2,4-dioxo-1-propyl-2,3,4,5-tetrahydro-1H-pyrrolo[3,2-d]pyrimidin-6-yl)-phenyloxy]-N-(4-fluorophenyl)acetamide 
• 480992-41-4 2-[4-(2,4-dioxo-1-propyl-2,3,4,5-tetrahydro-1H-pyrrolo[3,2-d]pyrimidin-6-yl)phenyloxy]-N-(4-bromophenyl)acetamide 

Relevant academic research and scientific papers

Synthesis and pharmacological evaluation of novel substituted 9-deazaxanthines as A2B receptor antagonists

A new series of 9-deazaxanthine derivatives with various substituents at the heterocyclic system were synthesized and evaluated for their binding affinities for the four human recombinant adenosine receptors, A 1A3 subtypes. A number